天坛生物：11月28日召开董事会会议

Company Overview - TianTan Biological (SH 600161) announced on November 28 that its 27th meeting of the 9th Board of Directors was held via telecommunication to review the proposal for amending the "Comprehensive Risk Management Measures" [1] - As of the report date, TianTan Biological has a market capitalization of 34.2 billion yuan [1] Industry Insights - For the first half of 2025, the revenue composition of TianTan Biological indicates that the biopharmaceutical sector accounts for 99.68% of its total revenue, while other businesses contribute 0.32% [1]